Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Journal: 

Lancet Diabetes Endocrinol

First published: October 3, 2024  DOI: 10.1016/S2213-8587(24)00221-3